Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies.
Autorzy:
Gan L; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University; Xiangya School of Public Health, Central South University; CSU-Sinocare Research Center for Nutrition and Metabolic Health; Furong Laboratory, Changsha, Hunan, 410011, China. Zhao B; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University; Xiangya School of Public Health, Central South University; CSU-Sinocare Research Center for Nutrition and Metabolic Health; Furong Laboratory, Changsha, Hunan, 410011, China. Inoue-Choi M; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA. Liao LM; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA. Graubard BI; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA. WeinsteinSJ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA. Albanes D; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA. . Huang J; National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University; Xiangya School of Public Health, Central South University; CSU-Sinocare Research Center for Nutrition and Metabolic Health; Furong Laboratory, Changsha, Hunan, 410011, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Mar 22; Vol. 22 (1), pp. 132. Date of Electronic Publication: 2024 Mar 22.
Evaluation of alcohol-free mouthwash for studies of the oral microbiome.
Autorzy:
Yano Y; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America. Vogtmann E; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America. Shreves AH; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America. WeinsteinSJ; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America. Black A; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America. Diaz-Mayoral N; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America. Wan Y; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America. Zhou W; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America. Hua X; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle Washington, United States of America. Dagnall CL; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America. Hutchinson A; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America. Jones K; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America. Hicks BD; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America. Wyatt K; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America. Brotzman M; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America. Gerlanc N; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America. Huang WY; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America. Albert PS; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America. Wentzensen N; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America. Abnet CC; Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Apr 27; Vol. 18 (4), pp. e0284956. Date of Electronic Publication: 2023 Apr 27 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
Lim JE; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD, 20892, USA. Huang J; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD, 20892, USA.; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China. WeinsteinSJ; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD, 20892, USA. Parisi D; Information Management Services, Calverton, MD, USA. Mӓnnistö S; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland. Albanes D; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD, 20892, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Mar 07; Vol. 13 (1), pp. 3776. Date of Electronic Publication: 2023 Mar 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural
A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort Consortium.
Autorzy:
Midttun Ø; Bevital AS, Laboratory Building, Jonas Lies Veg 87, 5021, Bergen, Norway. . Ulvik A; Bevital AS, Laboratory Building, Jonas Lies Veg 87, 5021, Bergen, Norway. Meyer K; Bevital AS, Laboratory Building, Jonas Lies Veg 87, 5021, Bergen, Norway. Zahed H; Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France. Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia. Manjer J; Department of Surgery, Skane University Hospital, Malmö, Sweden.; Lund University, Malmö, Sweden. Sandsveden M; Department of Clinical Sciences Malmo, Lund University, Malmö, Sweden. Langhammer A; Department of Public Health and Nursing, Hunt Research Centre, Norwegian University of Science and Technology, Levanger, Norway.; Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway. Sørgjerd EP; Department of Public Health and Nursing, Hunt Research Centre, Norwegian University of Science and Technology, Levanger, Norway.; Department of Endocrinology, St. Olavs Hospital, Trondheim University Hospital, Levanger, Norway. Behndig AF; Department of Public Health and Clinical Medicine, Umea University, Umeå, Sweden. Johansson M; Department of Radiation Sciences, Oncology, Umea University, Umeå, Sweden. Freedman ND; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Huang WY; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Chen C; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, USA. Prentice R; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, USA. Stevens VL; American Cancer Society, Atlanta, USA. Wang Y; American Cancer Society, Atlanta, USA. Le Marchand L; University of Hawai'i Cancer Center, University of Hawai'i at Mānoa, Honolulu, USA. WeinsteinSJ; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Cai Q; Vanderbilt University Medical Center, Nashville, USA. Arslan AA; Department of Obstetrics and Gynecology, NYU Langone Health, New York, NY, USA.; Department of Population Health, NYU Langone Health, New York, NY, USA.; Perlmutter Comprehensive Cancer Center, NYU Langone Health, New York, NY, USA. Chen Y; Department of Population Health, NYU Langone Health, New York, NY, USA.; Perlmutter Comprehensive Cancer Center, NYU Langone Health, New York, NY, USA. Shu XO; Department of Population Health, NYU Langone Health, New York, NY, USA. Zheng W; Department of Population Health, NYU Langone Health, New York, NY, USA. Yuan JM; University of Pittsburgh and UPMC Hillman Cancer Center, Pittsburgh, USA. Koh WP; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Visvanathan K; Johns Hopkins Institute for Clinical and Translational Research, Baltimore, USA. Sesso HD; Brigham and Women's Hospital, Harvard Medical School, Boston, USA.; Harvard T.H. Chan School of Public Health, Boston, USA. Zhang X; Brigham and Women's Hospital, Harvard Medical School, Boston, USA.; Harvard T.H. Chan School of Public Health, Boston, USA. Gaziano JM; Brigham and Women's Hospital, Boston, USA.; VA Boston Healthcare System, Boston, MA, USA. Fanidi A; Université Claude Bernard Lyon 1, Lyon, France. Robbins HA; Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France. Brennan P; Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France. Johansson M; Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France. Ueland PM; Bevital AS, Laboratory Building, Jonas Lies Veg 87, 5021, Bergen, Norway.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jan 18; Vol. 13 (1), pp. 1011. Date of Electronic Publication: 2023 Jan 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, P.H.S.
Interactions between folate intake and genetic predictors of gene expression levels associated with colorectal cancer risk.
Autorzy:
Haas CB; Department of Epidemiology, University of Washington, Seattle, WA, USA. .; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. . Su YR; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Petersen P; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Wang X; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Bien SA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Lin Y; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. WeinsteinSJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Jenkins MA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia. Figueiredo JC; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Department of Preventive Medicine and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Newcomb PA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; School of Public Health, University of Washington, Seattle, WA, USA. Casey G; Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA. Le Marchand L; University of Hawaii Cancer Center, Honolulu, HI, USA. Campbell PT; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA. Moreno V; Oncology Data Analytics Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.; ONCOBEL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. Potter JD; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Center for Public Health Research, Massey University, Wellington, New Zealand. Sakoda LC; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA. Slattery ML; Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA. Chan AT; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA. Li L; Department of Family Medicine, University of Virginia, Charlottesville, VA, USA. Giles GG; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia. Milne RL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia. Gruber SB; Department of Preventive Medicine and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Rennert G; Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel.; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.; Clalit National Cancer Control Center, Haifa, Israel. Woods MO; Memorial University of Newfoundland, Discipline of Genetics, St. John's, Canada. Gallinger SJ; Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. Berndt S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Hayes RB; Division of Epidemiology, Department of Population Health, New York University School of Medicine, New York, NY, USA. Huang WY; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Wolk A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. White E; Department of Epidemiology, University of Washington, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Nan H; IU Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN, USA. Nassir R; Department of Pathology, School of Medicine, Umm Al-Qura'a University, Makkah, Saudi Arabia. Lindor NM; Department of Health Science Research, Mayo Clinic, Scottsdale, AZ, USA. Lewinger JP; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Kim AE; Department of Preventive Medicine and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Conti D; Department of Preventive Medicine and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Gauderman WJ; Department of Preventive Medicine and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Buchanan DD; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, 3010, Australia.; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, VIC, 3010, Australia. Peters U; Department of Epidemiology, University of Washington, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Hsu L; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Nov 07; Vol. 12 (1), pp. 18852. Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
Metabolomic profile of prostate cancer-specific survival among 1812 Finnish men.
Autorzy:
Huang J; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. Zhao B; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China. WeinsteinSJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. . Mondul AM; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, 48109, USA. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2022 Oct 25; Vol. 20 (1), pp. 362. Date of Electronic Publication: 2022 Oct 25.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
Metabolomic analysis of serum alpha-tocopherol among men in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
Autorzy:
Lawrence WR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. . Lim JE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Huang J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China. Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. WeinsteinSJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. .
Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults.
Autorzy:
Zahed H; Genomic Epidemiology Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France. Johansson M; Genomic Epidemiology Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France. Ueland PM; Department of Clinical Science, University of Bergen, Bergen, Norway. Midttun Ø; Bevital AS, Bergen, Norway. Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia. Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia. Manjer J; Department of Surgery, Skane University Hospital, Malmö, Sweden.; Lund University, Malmö, Sweden. Sandsveden M; Department of Clinical Sciences Malmo, Lund University, Malmö, Sweden. Langhammer A; Department of Public Health and Nursing, Hunt Research Centre, Norwegian University of Science and Technology, Levanger, Norway.; Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway. Sørgjerd EP; Department of Public Health and Nursing, NTNU, Hunt Research Centre, Norwegian University of Science and Technology, Levanger, Norway.; Department of Endocrinology, St. Olavs Hospital, Trondheim University Hospital, Levanger, Norway. Grankvist K; Department of Medical Biosciences, Umea University, Umeå, Sweden. Johansson M; Department of Radiation Sciences, Oncology, Umea University, Umeå, Sweden. Freedman ND; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Huang WY; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Chen C; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA. Prentice R; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA. Stevens VL; American Cancer Society, Atlanta, USA. Wang Y; American Cancer Society, Atlanta, USA. Le Marchand L; University of Hawai'i Cancer Center, University of Hawai'i at Mānoa, Honolulu, USA. Wilkens LR; University of Hawai'i Cancer Center, University of Hawai'i at Mānoa, Honolulu, USA. WeinsteinSJ; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Albanes D; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Cai Q; Vanderbilt University Medical Center, Nashville, USA. Blot WJ; Vanderbilt University Medical Center, Nashville, USA. Arslan AA; Department of Obstetrics and Gynecology, NYU Langone Health, New York, NY, USA.; Department of Population Health, NYU Langone Health, New York, NY, USA.; Perlmutter Comprehensive Cancer Center, NYU Langone Health, New York, NY, USA. Zeleniuch-Jacquotte A; Department of Population Health, NYU Langone Health, New York, NY, USA.; Perlmutter Comprehensive Cancer Center, NYU Langone Health, New York, NY, USA. Shu XO; Vanderbilt University Medical Center, Nashville, USA. Zheng W; Vanderbilt University Medical Center, Nashville, USA. Yuan JM; University of Pittsburgh Medical Center, Pittsburgh, USA. Koh WP; Duke - NUS Medical School, Singapore, Singapore. Visvanathan K; Johns Hopkins Institute for Clinical and Translational Research, Baltimore, USA. Sesso HD; Brigham and Women's Hospital, Harvard Medical School, Boston, USA.; Harvard T.H. Chan School of Public Health, Boston, USA. Zhang X; Brigham and Women's Hospital, Harvard Medical School, Boston, USA.; Harvard T.H. Chan School of Public Health, Boston, USA. Gaziano JM; Harvard T.H. Chan School of Public Health, Boston, USA.; Brigham and Women's Hospital, Boston, USA. Fanidi A; Université Claude Bernard Lyon 1, Lyon, France. Muller D; Imperial College London School of Public Health, London, UK. Brennan P; Genomic Epidemiology Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France. Guida F; Genomic Epidemiology Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France. Robbins HA; Genomic Epidemiology Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jul 05; Vol. 11 (1), pp. 13805. Date of Electronic Publication: 2021 Jul 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses.
Autorzy:
Seyed Khoei N; Department of Nutritional Sciences, Faculty of Life Sciences, University of Vienna, Vienna, Austria. Jenab M; Nutritional Epidemiology Group, Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France. Murphy N; Nutritional Epidemiology Group, Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France. Banbury BL; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Carreras-Torres R; Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet de Llobregat, Barcelona, Spain. Viallon V; Nutritional Methodology and Biostatistics Group, Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69372, Lyon CEDEX 08, France. Kühn T; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Bueno-de-Mesquita B; Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Department of Gastroenterology and Hepatology, University Medical Center, Utrecht, The Netherlands.; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.; Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Aleksandrova K; Group Nutrition, Immunity and Metabolism, Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany. Cross AJ; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. Weiderpass E; International Agency for Research on Cancer (IARC-WHO), Lyon, France. Stepien M; Nutritional Epidemiology Group, Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France. Bulmer A; School of Medicine, Griffith University, Brisbane, QLD, Australia.; Alliance for Vascular Access Teaching and Research (AVATAR), Menzies Health Institute Queensland, Griffith University, Brisbane, QLD, Australia. Tjønneland A; Danish Cancer Society Research Center, Copenhagen, Denmark.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark. Boutron-Ruault MC; CESP (Centre de Recherche en Epidémiologie et Santé des Populations), Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.; Institut Gustave Roussy, Villejuif, France. Severi G; CESP (Centre de Recherche en Epidémiologie et Santé des Populations), Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.; Institut Gustave Roussy, Villejuif, France. Carbonnel F; CESP (Centre de Recherche en Epidémiologie et Santé des Populations), Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.; Institut Gustave Roussy, Villejuif, France.; Department of Gastroenterology, Bicêtre University Hospital, Public Assistance Hospitals of Paris, Le Kremlin Bicêtre, France. Katzke V; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Boeing H; Department of Epidemiology, German Institute of Human Nutrition Postdam-Rehbrücke, Nuthetal, Germany. Bergmann MM; Department of Epidemiology, German Institute of Human Nutrition Postdam-Rehbrücke, Nuthetal, Germany. Trichopoulou A; Hellenic Health Foundation, Athens, Greece. Karakatsani A; Hellenic Health Foundation, Athens, Greece.; 2nd Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, 'ATTIKON' University Hospital, Haidari, Greece. Martimianaki G; Hellenic Health Foundation, Athens, Greece. Palli D; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy. Tagliabue G; Lombardy Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Panico S; Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy. Tumino R; Cancer Registry and Histopathology Department, 'M.P. Arezzo' Hospital, ASP Ragusa, Ragusa, Italy. Sacerdote C; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy. Skeie G; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø (UiT), The Arctic University of Norway, Tromsø, Norway.; Nutritional Epidemiology Group, School of Food and Nutrition, University of Leeds, Leeds, UK. Merino S; Public Health Directorate, Asturias, Spain. Bonet C; Cancer Epidemiology Research Program, Unit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain. Rodríguez-Barranco M; Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria, ibs. GRANADA, Universidad de Granada, Granada, Spain.; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain. Gil L; Public Health Division of Gipuzkoa-BIODONOSTIA, Basque Regional Health Department, San Sebastian, Spain. Chirlaque MD; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain. Ardanaz E; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Navarra Public Health Institute, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. Myte R; Department of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden. Hultdin J; Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden. Perez-Cornago A; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Aune D; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.; Department of Nutrition, Bjørknes University College, Oslo, Norway.; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway. Tsilidis KK; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece. Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Baron JA; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA. Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Bézieau S; Service de Génétique Médicale, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France. Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. Campbell PT; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA. Casey G; Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA. Chan AT; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA. Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; University Medical Centre Hamburg-Eppendorf, University Cancer Centre Hamburg (UCCH), Hamburg, Germany. Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Cotterchio M; Prevention and Cancer Control, Cancer Care Ontario, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. Gallinger S; Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. Gruber SB; Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Haile RW; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA. Hampe J; Department of Medicine I, University Hospital Dresden, Technische Universität Dresden (TU Dresden), Dresden, Germany. Hoffmeister M; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Epidemiology, School of Public Health and Institute of Health and Environment, Seoul National University, Seoul, South Korea. Hsu L; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington, Seattle, WA, USA. Huyghe JR; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Jenkins MA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia. Joshi AD; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA. Kampman E; Division of Human Nutrition, Wageningen University and Research, Wageningen, The Netherlands. Larsson SC; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Le Marchand L; University of Hawaii Cancer Center, Honolulu, HI, USA. Li CI; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Li L; Department of Family Medicine, University of Virginia, Charlottesville, VA, USA. Lindblom A; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. Lindor NM; Department of Health Science Research, Mayo Clinic, Scottsdale, AZ, USA. Martín V; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Biomedicine Institute (IBIOMED), University of León, León, Spain. Moreno V; Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet de Llobregat, Barcelona, Spain.; Cancer Epidemiology Research Program, Unit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain. Newcomb PA; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA. Offit K; Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA.; Department of Medicine, Weill Cornell Medical College, New York, USA. Ogino S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. Parfrey PS; The Clinical Epidemiology Unit, Memorial University Medical School, Newfoundland, Canada. Pharoah PDP; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. Rennert G; Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel.; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.; Clalit National Cancer Control Center, Haifa, Israel. Sakoda LC; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA. Schafmayer C; Department of General, Visceral, Vascular, and Transplantation Surgery, University Hospital Rostock, Rostock, Germany. Schmit SL; Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Schoen RE; Department of Medicine and Epidemiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Slattery ML; Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA. Thibodeau SN; Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Ulrich CM; Huntsman Cancer Institute and Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA. van Duijnhoven FJB; Division of Human Nutrition, Wageningen University and Research, Wageningen, The Netherlands. Weigl K; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Faculty, University of Heidelberg, Heidelberg, Germany. WeinsteinSJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. White E; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA. Wolk A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Woods MO; Discipline of Genetics, Memorial University of Newfoundland, St. John's, Canada. Wu AH; University of Southern California, Preventative Medicine, Los Angeles, CA, USA. Zhang X; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Ferrari P; Nutritional Methodology and Biostatistics Group, Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69372, Lyon CEDEX 08, France. Anton G; Institute of Epidemiology, Helmholtz Zentrum Munich, Neuherberg, Germany. Peters A; Institute of Epidemiology, Helmholtz Zentrum Munich, Neuherberg, Germany. Peters U; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA. Gunter MJ; Nutritional Epidemiology Group, Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France. Wagner KH; Department of Nutritional Sciences, Faculty of Life Sciences, University of Vienna, Vienna, Austria. Freisling H; Nutritional Methodology and Biostatistics Group, Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69372, Lyon CEDEX 08, France. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2020 Sep 03; Vol. 18 (1), pp. 229. Date of Electronic Publication: 2020 Sep 03.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
Autorzy:
Song M; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Camargo MC; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. WeinsteinSJ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Murphy G; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Freedman ND; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Koshiol J; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Stolzenberg-Solomon RZ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Abnet CC; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Männistö S; Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland. Albanes D; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Rabkin CS; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.
Autorzy:
Loftfield E; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America. O'Brien TR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America. Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America. Howell CD; Department of Medicine, Howard University College of Medicine, Washington, DC, United States of America. Horst R; Heartland Assays, Ames, IA, United States of America. Prokunina-Olsson L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America. WeinsteinSJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America. Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America. Morgan TR; VA Long Beach Healthcare System, Long Beach, CA, United States of America. Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 Nov 10; Vol. 11 (11), pp. e0166036. Date of Electronic Publication: 2016 Nov 10 (Print Publication: 2016).
Serum Metabolomic Response to Long-Term Supplementation with all-rac - α -Tocopheryl Acetate in a Randomized Controlled Trial.
Autorzy:
Mondul AM; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA. Moore SC; Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Nutritional Epidemiology Branch, Bethesda, MD, USA. WeinsteinSJ; Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Nutritional Epidemiology Branch, Bethesda, MD, USA. Evans AM; Metabolon, Inc., Durham, NC, USA. Karoly ED; Metabolon, Inc., Durham, NC, USA. Männistö S; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland. Sampson JN; Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Biostatistics Branch, Bethesda, MD, USA. Albanes D; Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Nutritional Epidemiology Branch, Bethesda, MD, USA.
Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma.
Autorzy:
Purdue MP; 1] Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA [2] Ontario Institute for Cancer Research, Toronto, ON, Canada. Lan Q; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA. Kemp TJ; HPV Immunology Laboratory, Leidos Biomedical Incorporated, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. Hildesheim A; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA. WeinsteinSJ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA. Hofmann JN; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA. Virtamo J; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland. Albanes D; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA. Pinto LA; HPV Immunology Laboratory, Leidos Biomedical Incorporated, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. Rothman N; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, MD, USA.
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2015 Jun; Vol. 29 (6), pp. 1429-31. Date of Electronic Publication: 2014 Jan 08.
Typ publikacji:
Comparative Study; Letter; Research Support, N.I.H., Intramural
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
